Clinical trials and their availability for treatment of patients serve as a longstanding foundation in the practice of medicine and drug development. Through all phases of study (I-IV), the ...
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement Clinical trial eligibility ...
A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill clinical trials and enroll sufficiently diverse groups of patients for results to reflect the ...
This is a preview. Log in through your library . Abstract Background: High rates of failure to qualify for clinical trial participation increase time and cost required for study completion.
Background: Double-blind placebo-controlled trials are intended to control for the impact of expectancy on outcomes. Whether they always achieve this is, however, questionable. Methods: Reanalysis of ...
(RTTNews) - Dannish healthcare company Novo Nordisk A/S (NVO) said it has decided to stop the once-weekly injectable semaglutide kidney outcomes trial FLOW at interim, as per a recommendation from the ...
The guidances released by the FDA to expand inclusion criteria for cancer clinical trials is a step in the right direction, said Katie Goodman, RN, BSN, CCRP, director of clinical research, Florida ...